189
Views
7
CrossRef citations to date
0
Altmetric
Review

Vitamin D in asthma and future perspectives

, , , , , , , , , , & show all
Pages 1003-1013 | Published online: 23 Sep 2013

Abstract

Humans have the ability to synthesize vitamin D during the action of ultraviolet (UV) radiation upon the skin. Apart from the regulation of calcium and phosphate metabolism, another critical role for vitamin D in immunity and respiratory health has been revealed, since vitamin D receptors have also been found in other body cells. The term “vitamin D insufficiency” has been used to describe low levels of serum 25-hydroxyvitamin D that may be associated with a wide range of pulmonary diseases, including viral and bacterial respiratory infection, asthma, chronic obstructive pulmonary disease, and cancer. This review focuses on the controversial relationship between vitamin D and asthma. Also, it has been found that different gene polymorphisms of the vitamin D receptor have variable associations with asthma. Other studies investigated the vitamin D receptor signaling pathway in vitro or in experimental animal models and showed either a beneficial or a negative effect of vitamin D in asthma. Furthermore, a range of epidemiological studies has also suggested that vitamin D insufficiency is associated with low lung function. In the future, clinical trials in different asthmatic groups, such as infants, children of school age, and ethnic minorities are needed to establish the role of vitamin D supplementation to prevent and/or treat asthma.

Introduction

According to the Global Initiative for Asthma, bronchial asthma is a chronic inflammatory disorder that is related with hyperresponsiveness of the airways and leads to repeated episodes of wheezing, dyspnea, chest tightness, and cough, particularly at night or early in the morning. These episodes are usually associated with extensive but variable bronchial obstruction, which is often reversible, either spontaneously or after treatment. Medical therapy involves two different classes of medication – inhaled corticosteroids used as daily controller and beta-adrenergic agonists used for bronchodilation.Citation1

Asthma has become one of the most prevalent diseases worldwide causing a major public health concern. While there is evidence that the condition of asthma is multifactorial in etiology, changing environmental factors may underlie the rising prevalence of asthma, such as atmospheric pollution, dietary changes, allergens, improvements in health and hygiene, and lifestyle changes. Among nutritional hypotheses, vitamin D status is of particular interest regarding the controversial beneficial effects in non-skeletal disorders, such as cardiovascular disease, cancer, schizophrenia, multiple sclerosis, and asthma.Citation2Citation6

Recently, the governments of the United States (USA) and Canada supported the initiative of the Institute of Medicine (IOM) to update the nutrient reference values, known as Dietary Reference Intake (DRI), including vitamin D status. The DRI for vitamin D was evidence based, as carried out by the US Department of Health and Human Services Agency for Healthcare Research and Quality,Citation7,Citation8 selecting bone health as a composite indicator. Dose (intake)-response, values for UL, and serum 25-hydroxyvitamin D [25(OH)D] were considered as the best indicators for setting the DRI. Due to variations in sunlight exposure and the variable response to that exposure, as well as the concept against sun exposure to reduce the risk of skin cancer, the establishment of DRI for vitamin D was based on the assumption of minimal or no sunlight exposure. However, inconsistent data suggest that sun exposure currently contributes meaningful amounts of vitamin D.Citation6 Therefore, determining intake levels for vitamin D is somewhat more complicated.

It is recommended that the vitamin D status, assessed by the serum 25(OH)D concentration, be measured by a reliable assay.Citation9,Citation10 The 2011 DRI for vitamin D associated <30 nmol/L with an increased risk of deficiency, <40 nmol/L with risk of inadequacy, and ≥50 nmol/L but <125 nmol/L with adequacy and safety.Citation6 IOM for Canada and the USA specifies that – in the absence of sunshine – a recommended dietary allowance (RDA) of 600 International Units (IU)/day (15 μg/day) of vitamin D will provide a serum 25(OH)D concentration of at least 50 nmol/L. Similarly, The Endocrine Society’s guidelines recommend 400–1,000 IU for children and 1,500–2,000 IU for adults for the maintenance of serum 25(OH)D levels above 30 ng/mL for preventing and treating vitamin D deficiency.Citation10 Vitamin D deficiencies might cause rickets and insufficiency might be associated with immune dysfunction.Citation11 It is also a fact that serum concentrations of 25(OH)D above 30 ng/mL (75 nmol/L) are not consistently associated with increased benefit, and 25(OH)D levels above 50 ng/mL (125 nmol/L) might be responsible for some disease risks, challenging the thought that “more is better.”Citation12

Currently, a growing body of literature supports an association between serum vitamin D levels and respiratory infections attributable to the immunomodulatory properties of vitamin D.Citation13 This interaction is important for individuals with asthma, as respiratory infections may influence the frequency, severity, and duration of asthmatic symptoms.Citation14 In this study, we review the existing relevant literature focusing on epidemiological and interventional studies over the past decade and propose directions for future research.

Vitamin D overview: in vitro and in vivo models

Humans have a combination of vitamins D2 (ergocalciferol) and D3 (cholecalciferol), both produced by exposure to ultraviolet (UV) radiation. Vitamin D2 is synthesized during UV radiation of ergosterol, whereas vitamin D3 is produced by UV radiation (290–315 nm) exposure of the skin by converting 7-dehydrocholesterol in the skin to previtamin D3 and, subsequently, to vitamin D3.Citation6,Citation15,Citation16 Both vitamins are converted in the liver to 25(OH)D, via the action of 25-hydroxylases. Then, 1α-hydroxylase converts 25(OH)D to 1,25-dihydroxyvitamin D [1,25(OH)2D], primarily generated in the kidneys. 1,25(OH)2D binds to vitamin D receptors on cell membranes and becomes part of the steroid hormone nuclear receptor complex, verifying its classification as a steroid hormone.Citation15 The biologically active form of vitamin D [1,25(OH)2D], also known as calcitriol, binds to the nuclear vitamin D receptor (VDR), a ligand-regulated transcription factor to mediate its effectCitation17 ().

Figure 1 Vitamin D metabolic pathway per system.

Abbreviations: PTH, parathyroid hormone; 1,25(OH)2D, 1,25-dihydroxyvitamin D; 25(OH)D, serum 25-hydroxyvitamin D.
Figure 1 Vitamin D metabolic pathway per system.

Although vitamins D2 and D3 result in the same active metabolite (calcitriol), several studies have shown that they differ in their effectiveness in raising serum 25(OH)D concentrations – the established marker of vitamin D status.Citation12,Citation18Citation21

Overall, humans have a combination of vitamins D2 and D3 available to them as part of a typical lifestyle from ambient UV exposure (vitamin D3), habitual dietary intakes of vitamin D3-rich foods (egg yolks and oily fish), fortified foods (margarine and breakfast cereals, which generally have vitamin D2 fortification), and vitamin supplements in which both vitamins D2 and D3 are available.Citation6

It has been recently found that genetic variants in the vitamin D receptor (VDR) are variably associated with the risk of asthma development.Citation22 VDR is also a critical molecule in calcium metabolism and bone turnover or other immune and inflammatory disorders.Citation23 Furthermore, the vitamin D pathway has revealed a number of polymorphisms in its components, such as the vitamin D receptor VDR, the major receptor for the bioactive form of 25(OH)D, the microsomal vitamin D hydroxylase CYP2R1, and the vitamin D-binding protein GC.

Several research groups have studied VDR and CYP2R1 variants with contradictory results,Citation24Citation29 possibly due to linkage disequilibrium between typed markers or the diverse population studied. Recent studies investigated VDR gene polymorphisms, CYP2R1 variants, and susceptibility in Tunisian,Citation30 Chinese,Citation31,Citation32 and African American populations,Citation33 with inconsistent results ().

Table 1 Studies investigating VDR gene polymorphisms, CYP2R1 variants, and asthma susceptibility in different populations

Moreover, several studies have investigated the vitamin D receptor signal pathway in vitroCitation34 or in experimental animal models,Citation35 showing the beneficial effect of vitamin D in asthma. In contrast, the hypothesis that VDR levels play a negative role in asthma was reinforced by Wittke et al, who observed that vitamin D receptor-deficient mice failed to develop experimental allergic asthma.Citation26 Other relevant studies reported that vitamin D3 can potentially increase the therapeutic response to glucocorticoids in steroid-resistant patientsCitation36,Citation37 or have identified an additional pathway via which vitamin D can restrain inflammation in the airways to maintain respiratory health.Citation35 Also, vitamin D has been shown to influence the function of cells intrinsic to innate and adaptive immunity.Citation34

Vitamin D action relevant to asthma

Although several studies have reported an association between vitamin D and asthma, to date no study has fully described the mechanisms of vitamin D action relevant to asthma. Examples of vitamin D actions in asthma include improvement of immune function in lung tissues by protecting individuals from developing respiratory infections that could trigger asthmaCitation38Citation40 or overcoming steroid resistance by upregulation of IL-10 production from CD4+ T cells.Citation36 Upregulation of antimicrobial proteins,Citation41 such as beta defensins and cathelicidins (eg, hCAP-18 or LL-37),Citation42 and anti-inflammatory,Citation37 antiproliferativeCitation43 effects on airway smooth muscle, decelerating cell cycling, and decreasing hyperplasiaCitation44 also include examples of the important role of vitamin D in asthma. More specifically, cathelicidin, which is regulated by 1,25(OH)D, is a peptide active against Mycobacterium tuberculosis, gram positive and negative bacteria, viruses, and fungi.Citation45 It is a fact that people deficient in cathelicidin are more susceptible to mucosal infections. Furthermore, 1,25(OH)2D3 induces secretion of antimicrobial activity against Pseudomonas aeruginosa.Citation46 Even though the mechanisms of vitamin D action in asthma are not clear, it is possible that vitamin D could decrease acute asthma severity and reduce lung remodeling.

Maternal/infant vitamin D status

Many cross-sectional studies have focused on dietary etiology of asthma with inconsistent resultsCitation47 (). Urban living environments,Citation48 obesity,Citation49 and poor nutrition,Citation50,Citation51 include risk factors responsible for both hypovitaminosis D and asthma. It is a fact that more women from different races are deficient in vitamin D, both before and during pregnancy.Citation52

Table 2 Studies relating vitamin D with respiratory disorder

Recently, given the early age of asthma onset, several studies focused their investigation on the role of maternal diet on risk of asthma in offspring.Citation53,Citation54 Maternal diet during pregnancy is a crucial factor, as it was recently hypothesized that the increased prevalence of asthma might be related to changing diet.Citation55 It is also a fact that higher maternal dietary vitamin D, E, and zinc intakes in pregnancy are associated with decreased risks of wheezing illnesses and asthma in young children.Citation56Citation59 Specifically, a higher maternal intake of vitamin D during pregnancy might decrease the risk of recurrent wheezing in early childhood.Citation59,Citation60 However, another study did not find any evidence regarding the associations between maternal intake of most foods during pregnancy and asthma, respiratory, and allergic outcomes in 5 year old children – except for apples and fish – which might reduce the risk of children developing asthma or atopic disease.Citation61 In a population-based birth cohort study of 1,669 children in Finland, it was observed that maternal vitamin D intake from foods during pregnancy might be negatively associated with risk of asthma and allergic rhinitis in childhood.Citation62

Given the maternal vitamin D deficiency and the potential impact on child skeletal health,Citation63 some countries have recommended supplementations.Citation64 In the UK, women who are pregnant or breastfeeding were advised to take 10 μg vitamin D per day;Citation65 whereas, recently the 2011 DRI for the US and Canada established 15 μg vitamin D per day.Citation6 The correct amount of supplementation has been a contradictory subject as the risk to the fetus during fetal development is uncertain.Citation52,Citation66

In many countries, early vitamin supplementation is given routinely to infants; therefore, several studies have reported the association between vitamin D supplementation in infancy and increased risk of atopy and allergic rhinitis later in life.Citation67Citation69 The DRI for the US and Canada established infant supplementation at 10 μg vitamin D per day (http://books.nap.edu/openbook.php?record_id=13050&page=1106). In a study conducted in northern Finland, it was found that the prevalence of asthma, atopy, and allergic rhinitis at age 31 years was higher in participants who had received vitamin D supplementation (>2,000 IU/day) regularly during the first year of their lives compared to others.Citation67

The majority of the studies have included serum 25(OH)D level as the indicator of overall vitamin D status, since 25(OH)D is the major circulating form of vitamin D.Citation70 One of the first relevant studies concluded that in a pregnant woman, her serum concentration of 25(OH)D was strongly predictive of her child’s 25(OH)D concentration at birth; infants of women who were deficient in vitamin D experienced depleted vitamin D concentrations in utero and were born with low stores.Citation71 High (>75 nmol/L) maternal serum vitamin D levels during late pregnancy have been associated with an increased likelihood of childhood eczema at 9 months and asthma at 9 years.Citation52

Another population-based study, in which serum levels of 25(OH)D in the cord blood were measured in newborns of New Zealand (N = 929), resulted in determinants of low vitamin D status, such as winter month of birth, non-European ethnicity, longer gestational age, younger maternal age, and a parental history of asthma.Citation72 Cross-sectional analyses concluded that higher maternal vitamin D levels were associated with decreased odds of maternal asthma but not associated with infant bronchiolitis.Citation73 However, Camargo et al,Citation74 in a study on cord blood 25(OH)D and risk of early childhood infection, concluded that cord-blood levels of 25(OH)D had inverse associations with risk of respiratory infection and childhood wheezing but no association with incident asthma.

Furthermore, a population birth cohort study in Australia explored the associations between perinatal conditions and the risk of hospital admission with asthma between the second and fifth birthday.Citation75 The researchers reported that the season-associated risk of childhood asthma was consistent with early pregnancy exposures, such as the winter flu season or low vitamin D. Recently, it was reported that higher maternal circulating 25(OH)D concentrations in pregnancy were independently associated with lower risk of lower respiratory tract infections in offspring in the first year of life and not with wheezing or asthma in childhood.Citation76 Additionally, measuring serum 25(OH)D at 34 weeks’ gestation in the mothers of 860 children born at term, showed no evidence that exposure to higher concentrations of 25(OH)D in maternal serum during late pregnancy increased the risk of childhood asthma, wheeze, or atopy.Citation77 Therefore, despite the therapeutic option for vitamin D supplementation in mothers during pregnancy or the lactating period, further research is needed to explore the risks of such development.

Vitamin D status in asthmatic children

As bronchial asthma is still the most common chronic disease of childhoodCitation78 and one of the leading causes of morbidity in children worldwide,Citation79 the number of studies concerning the association between vitamin D deficiency and asthma and allergies has recently increased significantly. Epidemiologic data in most of the reported studies suggest that low serum vitamin D (defined as circulating levels of 25(OH)D of <30 ng/mL) in children with asthma is associated with more symptoms, exacerbations, reduced lung function, increased medication usage, and severe disease.Citation80

The first study to examine the effect of fish oil supplementation on the clinical progress of mild and severe asthma in children was conducted by Machura et al.Citation81 They reported that after the eighth week, only slight improvement in the case of mild asthma was observed; the changes in lipids were within the normal range, although there was a significant increase in the 25(OH)D level. Other studies, which were conducted in diverse populations,Citation82Citation84 demonstrated that lower vitamin D levels were associated with increased markers of allergy and asthma severity in Costa Rican children.Citation82 In the study by Brehm in 2010, in North American children with mild-to-moderate persistent asthma who had an insufficient vitamin D status were found to be associated with higher odds of severe exacerbation over a 4-year period.Citation83 Also, recently in Puerto Rican children, vitamin D insufficiency was associated with severe asthma exacerbations, independently of racial ancestry, atopy, or markers of disease severity or control.Citation84

Several cross-sectional studies of vitamin D status in asthmatic children were conducted by several research groups in different populations. As vitamin D deficiency is more common among African American (AA) individuals, in particular from urban environments or with obesity,Citation85 Freishtat et al investigated urban AA youth with or without persistent asthma, comparing levels between asthmatic and control groups. They reported that AA youth with persistent asthma were vitamin D deficient or insufficient, suggesting a routine vitamin D testing in this population, especially those with asthma.

A survey in Spain indicated that sunny hours had a protective effect on the prevalence of asthma in schoolchildren.Citation86 In another cross-sectional study in Italian children, it was found that hypovitaminosis D was frequent in children with asthma living in a Mediterranean country, regardless of the sun exposure.Citation87 Moreover, lower levels of vitamin D were associated with reduced asthma control in those children.

An Australian multicenter study concluded that oral supplementation with cod liver oil in childhood increased the odds of a history of having asthma.Citation88 Additionally, vitamin D supplementation in children appears to prevent asthma exacerbation triggered by acute respiratory infection.Citation89

As far as lung function is concerned, serum 25(OH)D levels were shown to be inversely associated with asthma, and there was a direct and significant relationship between vitamin D levels and pulmonary function test outcomes in asthmatic children.Citation90 In addition, the first epidemiological study in the Middle East region concluded that vitamin D deficiency was the major predictor of asthma in Qatari children,Citation91 while the age-specific effects of vitamin D in asthmatic patients have also been examined.Citation92 The results demonstrated significant associations between serum vitamin D status and steroid requirement and in vitro responsiveness to corticosteroids in the pediatric, but not in the adult asthma group. Published studies that investigate the interaction of vitamin D with corticosteroid-mediated anti-inflammatory responses have started to accumulate. More recently, the same group of researchersCitation92 concluded that corticosteroid use and worsening airflow limitation were associated with lower vitamin D serum levels in asthmatic children.Citation93 They reported that vitamin D enhanced glucocorticoid action in peripheral blood mononuclear cells from asthmatic patients. In a randomized, double-blind, two-period crossover trial of asthmatic children, the researchers concluded that the administration of 25(OH)D did not affect short-term growth or markers of bone turnover in children with asthma treated with inhaled dry-powder budesonide (400 μg daily).Citation94 However, the beneficial effect of oral corticosteroids on allergen-specific immunotherapy was not confirmed. It was observed that the combined administration of a corticosteroid drug and allergen extract suppressed the early clinical and immunological effects of specific immunotherapy (SIT) and that vitamin D3 prevented this adverse influence of steroids.Citation95 Additionally, in children with asthma treated with inhaled corticosteroids, vitamin D deficiency (defined as 25(OH)D < 20 ng/mL) was associated with poorer lung function than in children with vitamin D insufficiency or sufficiency.Citation96

As vitamin D insufficiency has been related to decreased bone mineral density which is adversely affected by corticosteroids, Tse et alCitation97 sought to determine whether children with asthma who have lower vitamin D levels are more susceptible to the negative effects of corticosteroids on bone mineral density over time. They concluded that vitamin D levels significantly modified the effect of corticosteroids on bone mineral accretion (BMA) in boys. In spite of the inconsistency and the need for additional studies, the therapeutic benefit of vitamin D supplementation in asthmatic children has been revealed.

Vitamin D status in asthmatic adults

Some studies investigated the effects of vitamin D on the inception and severity of asthma on adults. The first study was conducted in patients with allergic bronchial asthma and found that when calcium was given orally in combination with calciferol (vitamin D2) there was a decrease in airway obstruction.Citation98 Similarly, one of the first prospective, controlled, and randomized clinical trials in asthmatics undergoing long-term treatment with systemically applied corticosteroids reported that the combination of ethane-1-hydroxy-1,1-diphosphonate (EHDP), calcium, and vitamin D appeared to be a useful regimen for the management of steroid-induced bone loss in adult asthmatics.Citation99

Since then, apart from the increased number of studies in childhood asthma, there are also a sufficient number of studies in asthmatic adults concerning their relation to vitamin D status. Regarding the treatment of steroid osteoporosis, calcium–D3 Nycomed (Nycomed, Zürich, Switzerland) was suggested to achieve a high clinical efficiency and absence of side effects in patients with hormone-dependent bronchial asthma.Citation100

The findings of a cross-sectional study including Chinese patients with newly diagnosed asthma concluded that vitamin D deficiency was highly prevalent and was associated with decreased lung function in this population.Citation101 Also, in asthmatic adult patients, reduced vitamin D levels were associated with impaired lung function, increased airway hyperresponsiveness, and reduced glucocorticoid response, suggesting that supplementation of vitamin D levels in these patients might improve multiple parameters of asthma severity and treatment response.Citation9 The first study to treat successfully a patient with reactive airways dysfunction syndrome was conducted by Varney et al.Citation102 Symptoms included ones that mimic asthma and, even though the patient appeared unresponsive to conventional asthma treatments, the patient responded to high-dose oral vitamin D supplements.

Several studies have suggested the active involvement of vascular endothelial growth factor (VEGF), a potent proangiogenic cytokine, in the pathogenesis of isocyanate occupational asthma, which might be mediated by 1,25-dihydroxychole-calciferol [1,25(OH)2D3], the active form of vitamin D.Citation103,Citation104 It was recently suggested that the serum vitamin D-binding protein level might be used as a serological marker for the detection of isocyanate-induced occupational asthma among workers exposed to isocyanate.Citation105 It was concluded that the toluene diisocyanate-induced VEGF production/secretion was reversed by 1,25(OH)2D3 treatment, which might provide also a potential therapeutic strategy for these patients. Another study focused on the relationship between serum concentrations of 25(OH)D and pulmonary function, using data from the Third National Health and Nutrition Examination Survey (N = 14,091).Citation106 It was demonstrated that there was a strong relationship between serum concentrations of 25(OH)D, forced expiratory volume 1 (FEV1), and forced vital capacity (FVC). However, Shaheen et al did not confirm a positive association between blood 25(OH)D concentrations and adult lung function,Citation107 reinforcing the inconsistency concerning the hypothesis of vitamin D ’s beneficial effects. Finally, a cross-sectional study in asthmatics and in nonasthmatics (N = 23), determining the correlation between serum 25(OH)D levels and pneumococcal antibody levels, reported that 25(OH)D might enhance humoral immunity against Streptococcus pneumoniae in subjects with atopic conditions, but not without atopic conditions.Citation108

Conclusion

Despite the growing evidence of the role of vitamin D in incident asthma and asthma exacerbation, studies are not all consistent. Some studies have supported the view that vitamin D deficiency is the cause of the global asthma epidemic.Citation2 On the other hand, another studyCitation109 has proposed that vitamin D supplements are the cause of the asthma epidemic. In fact, the concept “more is better” has been challenged, given that higher levels of vitamin D status have not been shown to greatly benefit asthmatic patients, but they have been associated with diverse health problems.

There are several confounding factors that could influence the relationship between vitamin D levels and asthma development, such as the fact that asthmatic subjects spend more time indoors, are less physically active, and therefore are exposed less to sunlight.Citation110 Other factors include the insufficient number of subjects studied, or the unequal sex distribution in groups studied.Citation90 As a result, the IOM, after reviewing recent literature regarding vitamin D, concluded that there were insufficient data to recommend vitamin D supplementation for the prevention of nonbone-related diseases.Citation6

To our knowledge, there are no studies available on whether age is a crucial factor in regulating the role of vitamin D in asthma. A study analyzed data from the Third National Health and Nutrition Examination Survey (1988–1994) with linked mortality files through 2006. The researchers divided asthmatics into two groups – younger adults (17–54 years of age) and older adults (55 years or older) – and reported that ethnic differences in asthma mortality and the vitamin D-mortality link merited further investigation.Citation111

Lastly, Litonjua,Citation112 in his review, examined whether the administration of vitamin D enhances corticosteroid actions and potentially reverses steroid resistance, a crucial topic for asthmatic patients. As it has already been mentioned in the present review, several clinical and observational studies have suggested a synergistic effect of vitamin D and corticosteroids in asthma outcomes.Citation83,Citation92,Citation93,Citation96 However, larger studies, including both children and adults are needed to shed light on the circulating level and dose of vitamin D that can result in the greatest potential for synergy with steroids. In spite of some potential mechanisms of this interaction that have been reported, such as the induction of IL-10-secreting T regulatory cells,Citation36 further studies in asthma cell models are required to clarify whether it is the vitamin D or the corticosteroid effects that are primarily operating in asthma.

Future perspectives

In spite of the inconsistency, most of the cross-sectional and prospective studies have revealed the benefit of vitamin D supplementation in asthmatic patients. However, more clinical trials are required to demonstrate the levels of vitamin D, which differ according to individual characteristics. Randomized controlled trials of calcium and vitamin D often fail, raising an important problem.Citation113 The fact that serum 25(OH)D concentrations have a sigmoidal relationship with respect to oral vitamin D intake, meaning that for a given dose, the increase is much larger for people with low initial concentrations than for people with higher concentrations. Thus, it is important that serum 25(OH)D concentrations are measured at least two or three times during the studies, since it is serum 25(OH)D concentration, not vitamin D intake that affects risk of disease.

As vitamin D deficiency is prevalent in sun-replete areas, it is also essential to determine the optimal timing of vit D measurement. Furthermore, dietary vitamin D-mediated intervention in prevention and management of asthma will be enhanced when researchers shed more light on molecular epigenetic mechanism of vitamin D/VDR. All these data suggest that a continuous demand for 25(OH)D measurements will exist for many years to come.

Acknowledgments

Supported by Shanghai Municipal Natural Science Foundation of China (Grant No 13ZR1408900). was created by Paul Zarogoulidis.

Disclosure

The authors report no conflicts of interest in this work.

References

  • Guidelines: GINA Report GSfAMaP Global Initiative for Asthma (GINA) 2012 Available from http://www.ginasthma.org/documents/4 Accessed August 29, 2013
  • Litonjua AA Weiss ST Is vitamin D deficiency to blame for the asthma epidemic? J Allergy Clin Immunol 2007 120 5 1031 1035 17919705
  • Wang TJ Pencina MJ Booth SL Vitamin D deficiency and risk of cardiovascular disease Circulation 2008 117 4 503 511 18180395
  • Toner CD Davis CD Milner JA The vitamin D and cancer conundrum: aiming at a moving target J Am Diet Assoc 2010 110 10 1492 1500 20869488
  • Rosen CJ Adams JS Bikle DD The nonskeletal effects of vitamin D: an Endocrine Society scientific statement Endocr Rev 2012 33 3 456 492 22596255
  • Ross AC Manson JE Abrams SA The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know J Clin Endocrinol Metab 2011 96 1 53 58 21118827
  • Cranney A Horsley T O’Donnell S Effectiveness and safety of vitamin D in relation to bone health Evid Rep Technol Assess (Full Rep) 2007 158 1 235 18088161
  • Chung M Balk EM Brendel M Vitamin D and calcium: a systematic review of health outcomes Evid Rep Technol Assess (Full Rep) 2009 183 1 420 20629479
  • Sutherland ER Goleva E Jackson LP Stevens AD Leung DY Vitamin D levels, lung function, and steroid response in adult asthma Am J Respir Crit Care Med 2010 181 7 699 704 20075384
  • Holick MF Binkley NC Bischoff-Ferrari HA Endocrine Society Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline J Clin Endocrinol Metab 2011 96 7 1911 1930 21646368
  • Rosen CJ Clinical practice. Vitamin D insufficiency N Engl J Med 2011 364 3 248 254 21247315
  • Vieth R Implications for 25-hydroxyvitamin D testing of public health policies about the benefits and risks of vitamin D fortification and supplementation Scand J Clin Lab Invest Suppl 2012 243 144 153 22536776
  • Ginde AA Mansbach JM Camargo CAJr Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey Arch Intern Med 2009 169 4 384 390 19237723
  • van Elden LJ Sachs AP van Loon AM Enhanced severity of virus associated lower respiratory tract disease in asthma patients may not be associated with delayed viral clearance and increased viral load in the upper respiratory tract J Clin Virol 2008 41 2 116 121 18096430
  • Borradale D Kimlin M Vitamin D in health and disease: an insight into traditional functions and new roles for the ‘sunshine vitamin’ Nutr Res Rev 2009 22 2 118 136 19900346
  • Dixon KM Tongkao-On W Sequeira VB Vitamin d and death by sunshine Int J Mol Sci 2013 14 1 1964 1977 23334476
  • Bossé Y Lemire M Poon AH Asthma and genes encoding components of the vitamin D pathway Respir Res 2009 10 98 19852851
  • Trang HM Cole DE Rubin LA Pierratos A Siu S Vieth R Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2 Am J Clin Nutr 1998 68 4 854 858 9771862
  • Romagnoli E Mascia ML Cipriani C Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly J Clin Endocrinol Metab 2008 93 8 3015 3020 18492750
  • Holick MF Biancuzzo RM Chen TC Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D J Clin Endocrinol Metab 2008 93 3 677 681 18089691
  • Biancuzzo RM Young A Bibuld D Fortification of orange juice with vitamin D(2) or vitamin D(3) is as effective as an oral supplement in maintaining vitamin D status in adults Am J Clin Nutr 2010 91 6 1621 1626 20427729
  • Rogers AJ Raby BA Lasky-Su JA Assessing the reproducibility of asthma candidate gene associations, using genome-wide data Am J Respir Crit Care Med 2009 179 12 1084 1090 19264973
  • Pfeffer PE Hawrylowicz CM Vitamin D and lung disease Thorax 2012 67 11 1018 1020 22935474
  • Hewison M Freeman L Hughes SV Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells J Immunol 2003 170 11 5382 5390 12759412
  • Overbergh L Decallonne B Waer M 1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543) Diabetes 2000 49 8 1301 1307 10923629
  • Wittke A Weaver V Mahon BD August A Cantorna MT Vitamin D receptor-deficient mice fail to develop experimental allergic asthma J Immunol 2004 173 5 3432 3436 15322208
  • van Etten E Verlinden L Giulietti A The vitamin D receptor gene FokI polymorphism: functional impact on the immune system Eur J Immunol 2007 37 2 395 405 17274004
  • Poon AH Laprise C Lemire M Association of vitamin D receptor genetic variants with susceptibility to asthma and atopy Am J Respir Crit Care Med 2004 170 9 967 973 15282199
  • Raby BA Lazarus R Silverman EK Association of vitamin D receptor gene polymorphisms with childhood and adult asthma Am J Respir Crit Care Med 2004 170 10 1057 1065 15282200
  • Maalmi H Sassi FH Berraies A Ammar J Hamzaoui K Hamzaoui A Association of vitamin D receptor gene polymorphisms with susceptibility to asthma in Tunisian children: A case control study Hum Immunol 2013 74 2 234 240 23200756
  • Fang WL Gao LB Liang WB Association analysis of vitamin D receptor gene polymorphisms in chinese population with asthma Iran J Allergy Asthma Immunol 2009 8 3 141 147 20124605
  • Li F Jiang L Willis-Owen SA Zhang Y Gao J Vitamin D binding protein variants associate with asthma susceptibility in the Chinese Han population BMC Med Genet 2011 12 103 21810276
  • Pillai DK Iqbal SF Benton AS Associations between genetic variants in vitamin D metabolism and asthma characteristics in young African Americans: a pilot study J Investig Med 2011 59 6 938 946
  • Chambers ES Hawrylowicz CM The impact of vitamin D on regulatory T cells Curr Allergy Asthma Rep 2011 11 1 29 36 21104171
  • Dimeloe S Nanzer A Ryanna K Hawrylowicz C Regulatory T cells, inflammation and the allergic response-The role of glucocorticoids and Vitamin D J Steroid Biochem Mol Biol 2010 120 2–3 86 95 20227496
  • Xystrakis E Kusumakar S Boswell S Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients J Clin Invest 2006 116 1 146 155 16341266
  • Banerjee A Damera G Bhandare R Vitamin D and glucocorticoids differentially modulate chemokine expression in human airway smooth muscle cells Br J Pharmacol 2008 155 1 84 92 18552877
  • Urashima M Segawa T Okazaki M Kurihara M Wada Y Ida H Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren Am J Clin Nutr 2010 91 5 1255 1260 20219962
  • Brunetti L Colazzo D Francavilla R The role of pulmonary infection in pediatric asthma Allergy Asthma Proc 2007 28 2 190 193 17479603
  • Ginde AA Mansbach JM Camargo CAJr Vitamin D, respiratory infections, and asthma Curr Allergy Asthma Rep 2009 9 1 81 87 19063829
  • Liu PT Stenger S Tang DH Modlin RL Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin J Immunol 2007 179 4 2060 2063 17675463
  • Adams JS Hewison M Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity Nat Clin Pract Endocrinol Metab 2008 4 2 80 90 18212810
  • Damera G Fogle HW Lim P Vitamin D inhibits growth of human airway smooth muscle cells through growth factor-induced phosphorylation of retinoblastoma protein and checkpoint kinase 1 Br J Pharmacol 2009 158 6 1429 1441 19814732
  • Iqbal SF Freishtat RJ Mechanism of action of vitamin D in the asthmatic lung J Investig Med 2011 59 8 1200 1202
  • Kamen DL Tangpricha V Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity J Mol Med (Berl) 2010 88 5 441 450 20119827
  • Wang TT Nestel FP Bourdeau V Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression J Immunol 2004 173 5 2909 2912 15322146
  • McKeever TM Britton J Diet and asthma Am J Respir Crit Care Med 2004 170 7 725 729 15256393
  • Lee JM Smith JR Philipp BL Chen TC Mathieu J Holick MF Vitamin D deficiency in a healthy group of mothers and newborn infants Clin Pediatr (Phila) 2007 46 1 42 44 17164508
  • Gordon CM DePeter KC Feldman HA Grace E Emans SJ Prevalence of vitamin D deficiency among healthy adolescents Arch Pediatr Adolesc Med 2004 158 6 531 537 15184215
  • Moore CE Murphy MM Holick MF Vitamin D intakes by children and adults in the United States differ among ethnic groups J Nutr 2005 135 10 2478 2485 16177216
  • Pinto JM Schneider J Perez R DeTineo M Baroody FM Naclerio RM Serum 25-hydroxyvitamin D levels are lower in urban African American subjects with chronic rhinosinusitis J Allergy Clin Immunol 2008 122 2 415 417 18585770
  • Gale CR Robinson SM Harvey NC Princess Anne Hospital Study Group Maternal vitamin D status during pregnancy and child outcomes Eur J Clin Nutr 2008 62 1 68 77 17311057
  • Gern JE Lemanske RFJr Busse WW Early life origins of asthma J Clin Invest 1999 104 7 837 843 10510321
  • Warner JA Jones CA Jones AC Warner JO Prenatal origins of allergic disease J Allergy Clin Immunol 2000 105 2 Pt 2 S493 S498 10669530
  • Devereux G Maternal diet during pregnancy: an emerging risk factor for childhood asthma Expert Rev Clin Immunol 2008 4 6 663 668 20477115
  • Martindale S McNeill G Devereux G Campbell D Russell G Seaton A Antioxidant intake in pregnancy in relation to wheeze and eczema in the first two years of life Am J Respir Crit Care Med 2005 171 2 121 128 15531754
  • Devereux G Turner SW Craig LC Low maternal vitamin E intake during pregnancy is associated with asthma in 5-year-old children Am J Respir Crit Care Med 2006 174 5 499 507 16763215
  • Litonjua AA Rifas-Shiman SL Ly NP Maternal antioxidant intake in pregnancy and wheezing illnesses in children at 2 y of age Am J Clin Nutr 2006 84 4 903 911 17023719
  • Devereux G Litonjua AA Turner SW Maternal vitamin D intake during pregnancy and early childhood wheezing Am J Clin Nutr 2007 85 3 853 859 17344509
  • Camargo CAJr Rifas-Shiman SL Litonjua AA Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age Am J Clin Nutr 2007 85 3 788 795 17344501
  • Willers SM Devereux G Craig LC Maternal food consumption during pregnancy and asthma, respiratory and atopic symptoms in 5-year-old children Thorax 2007 62 9 773 779 17389754
  • Erkkola M Kaila M Nwaru BI Maternal vitamin D intake during pregnancy is inversely associated with asthma and allergic rhinitis in 5-year-old children Clin Exp Allergy 2009 39 6 875 882 19522996
  • Javaid MK Crozier SR Harvey NC Princess Anne Hospital Study Group Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study Lancet 2006 367 9504 36 43 16399151
  • Hollis BW Wagner CL Vitamin D requirements during lactation: high-dose maternal supplementation as therapy to prevent hypovitaminosis D for both the mother and the nursing infant Am J Clin Nutr 2004 80 6 Suppl 1752S 1758S 15585800
  • Dietary reference values for food energy and nutrients for the United Kingdom Report of the Panel on Dietary Reference Values of the Committee on Medical Aspects of Food Policy Rep Health Soc Subj (Lond) 1991 41 1 210 [No authors listed] 1961974
  • Hollis BW Wagner CL Nutritional vitamin D status during pregnancy: reasons for concern CMAJ 2006 174 9 1287 1290 16636329
  • Hyppönen E Sovio U Wjst M Infant vitamin d supplementation and allergic conditions in adulthood: northern Finland birth cohort 1966 Ann N Y Acad Sci 2004 1037 84 95 15699498
  • Bäck O Blomquist HK Hernell O Stenberg B Does vitamin D intake during infancy promote the development of atopic allergy? Acta Derm Venereol 2009 89 1 28 32 19197538
  • Kull I Bergström A Melén E Early-life supplementation of vitamins A and D, in water-soluble form or in peanut oil, and allergic diseases during childhood J Allergy Clin Immunol 2006 118 6 1299 1304 17157660
  • Holick MF Vitamin D deficiency N Engl J Med 2007 357 3 266 281 17634462
  • Hollis BW Pittard WB3rd Evaluation of the total fetomaternal vitamin D relationships at term: evidence for racial differences J Clin Endocrinol Metab 1984 59 4 652 657 6090493
  • Camargo CAJr Ingham T Wickens K New Zealand Asthma and Allergy Cohort Study Group Vitamin D status of newborns in New Zealand Br J Nutr 2010 104 7 1051 1057 20426893
  • Carroll KN Gebretsadik T Larkin EK Relationship of maternal vitamin D level with maternal and infant respiratory disease Am J Obstet Gynecol 2011 205 3 215. e1 e7 21658670
  • Camargo CAJr Ingham T Wickens K New Zealand Asthma and Allergy Cohort Study Group Cord-blood 25-hydroxyvitamin D levels and risk of respiratory infection, wheezing, and asthma Pediatrics 2011 127 1 e180 e187 21187313
  • Algert CS Bowen JR Lain SL Allen HD Vivian-Taylor JM Roberts CL Pregnancy exposures and risk of childhood asthma admission in a population birth cohort Pediatr Allergy Immunol 2011 22 8 836 842 21929593
  • Morales E Romieu I Guerra S INMA Project Maternal vitamin D status in pregnancy and risk of lower respiratory tract infections, wheezing, and asthma in offspring Epidemiology 2012 23 1 64 71 22082994
  • Pike KC Inskip HM Robinson S Southampton Women’s Survey Study Group Maternal late-pregnancy serum 25-hydroxyvitamin D in relation to childhood wheeze and atopic outcomes Thorax 2012 67 11 950 956 22707522
  • Masoli M Fabian D Holt S Beasley R Global Initiative for Asthma (GINA) Program The global burden of asthma: executive summary of the GINA Dissemination Committee report Allergy 2004 59 5 469 478 15080825
  • Mannino DM Homa DM Akinbami LJ Moorman JE Gwynn C Redd SC Surveillance for asthma – United States, 1980–1999 MMWR Surveill Summ 2002 51 1 1 13
  • Kunisaki KM Niewoehner DE Connett JE COPD Clinical Research Network Vitamin D levels and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study Am J Respir Crit Care Med 2012 185 3 286 290 22077070
  • Machura E Brus R Kalacinński W Lacheta M The effect of dietary fish oil supplementation on the clinical course of asthma in children Pediatr Pol 1996 71 2 97 102 Polish [with English abstract] 8966087
  • Brehm JM Celedón JC Soto-Quiros ME Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica Am J Respir Crit Care Med 2009 179 9 765 771 19179486
  • Brehm JM Schuemann B Fuhlbrigge AL Childhood Asthma Management Program Research Group Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study J Allergy Clin Immunol 2010 126 1 52 58. e5 20538327
  • Brehm JM Acosta-Pérez E Klei L Vitamin D insufficiency and severe asthma exacerbations in Puerto Rican children Am J Respir Crit Care Med 2012 186 2 140 146 22652028
  • Freishtat RJ Iqbal SF Pillai DK High prevalence of vitamin D deficiency among inner-city African American youth with asthma in Washington, DC J Pediatr 2010 156 6 948 952 20236657
  • Arnedo-Pena A García-Marcos L Fernández-Espinar JF Sunny hours and variations in the prevalence of asthma in schoolchildren according to the International Study of Asthma and Allergies (ISAAC) Phase III in Spain Int J Biometeorol 2011 55 3 423 434 20803035
  • Chinellato I Piazza M Sandri M Peroni D Piacentini G Boner AL Vitamin D serum levels and markers of asthma control in Italian children J Pediatr 2011 158 3 437 441 20870246
  • Hughes AM Lucas RM Ponsonby AL The role of latitude, ultraviolet radiation exposure and vitamin D in childhood asthma and hayfever: an Australian multicenter study Pediatr Allergy Immunol 2011 22 3 327 333 20880353
  • Majak P Olszowiec-Chlebna M Smejda K Stelmach I Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection J Allergy Clin Immunol 2011 127 5 1294 1296 21315433
  • Alyasin S Momen T Kashef S Alipour A Amin R The relationship between serum 25 hydroxy vitamin d levels and asthma in children Allergy Asthma Immunol Res 2011 3 4 251 255 21966605
  • Bener A Ehlayel MS Tulic MK Hamid Q Vitamin D deficiency as a strong predictor of asthma in children Int Arch Allergy Immunol 2012 157 2 168 175 21986034
  • Goleva E Searing DA Jackson LP Richers BN Leung DY Steroid requirements and immune associations with vitamin D are stronger in children than adults with asthma J Allergy Clin Immunol 2012 129 5 1243 1251 22330698
  • Searing DA Zhang Y Murphy JR Hauk PJ Goleva E Leung DY Decreased serum vitamin D levels in children with asthma are associated with increased corticosteroid use J Allergy Clin Immunol 2010 125 5 995 1000 20381849
  • Schou AJ Heuck C Wolthers OD Does vitamin D administered to children with asthma treated with inhaled glucocorticoids affect short-term growth or bone turnover? Pediatr Pulmonol 2003 36 5 399 404 14520722
  • Majak P Rychlik B Stelmach I The effect of oral steroids with and without vitamin D3 on early efficacy of immunotherapy in asthmatic children Clin Exp Allergy 2009 39 12 1830 1841 19817753
  • Wu AC Tantisira K Li L Fuhlbrigge AL Weiss ST Litonjua A Childhood Asthma Management Program Research Group Effect of vitamin D and inhaled corticosteroid treatment on lung function in children Am J Respir Crit Care Med 2012 186 6 508 513 22798322
  • Tse SM Kelly HW Litonjua AA Va n Natta ML Weiss ST Tantisira KG Childhood Asthma Management Program Research Group Corticosteroid use and bone mineral accretion in children with asthma: effect modification by vitamin D J Allergy Clin Immunol 2012 130 1 53 60. e4 22608570
  • Utz G Hauck AM Oral application of calcium and vitamin D2 in allergic bronchial asthma (author’s transl) MMW Munch Med Wochenschr 1976 118 43 1395 1398 German [with English abstract] 825744
  • Worth H Stammen D Keck E Therapy of steroid-induced bone loss in adult asthmatics with calcium, vitamin D, and a diphosphonate Am J Respir Crit Care Med 1994 150 2 394 397 8049820
  • Ememl’ianov AV Shevelev SE Murzin BA Amosov VI Efficiency of calcium and vitamin D3 in the treatment of steroid osteoporosis in patients with hormone dependent bronchial asthma Ter Arkh 1999 71 11 68 69 Russian [with English abstract] 10626343
  • Li F Peng M Jiang L Vitamin D deficiency is associated with decreased lung function in Chinese adults with asthma Respiration 2011 81 6 469 475 21124013
  • Varney VA Evans J Bansal AS Successful treatment of reactive airways dysfunction syndrome by high-dose vitamin D J Asthma Allergy 2011 4 87 91 22034572
  • Gruber HE Hoelscher G Ingram JA Chow Y Loeffler B Hanley ENJr 1,25(OH)2-vitamin D3 inhibits proliferation and decreases production of monocyte chemoattractant protein-1, thrombopoietin, VEGF, and angiogenin by human annulus cells in vitro Spine (Phila Pa 1976) 2008 33 7 755 765 18379402
  • Nakagawa K Kawaura A Kato S Takeda E Okano T 1alpha,25-Dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer Carcinogenesis 2005 26 2 429 440 15539405
  • Kim SH Choi GS Nam YH Role of vitamin D-binding protein in isocyanate-induced occupational asthma Exp Mol Med 2012 44 5 319 329 22314196
  • Black PN Scragg R Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey Chest 2005 128 6 3792 3798 16354847
  • Shaheen SO Jameson KA Robinson SM Relationship of vitamin D status to adult lung function and COPD Thorax 2011 66 8 692 698 21653927
  • Lee J Zhao H Fenta Y Kita H Kumar R Juhn YJ Serum 25-hydroxyvitamin D is associated with enhanced pneumococcal antibody levels in individuals with asthma Allergy Asthma Proc 2011 32 6 445 452 22221439
  • Wjst M Dold S Genes, factor X, and allergens: what causes allergic diseases? Allergy 1999 54 7 757 759 10442534
  • Weiss ST Litonjua AA Maternal diet vs lack of exposure to sunlight as the cause of the epidemic of asthma, allergies and other autoimmune diseases Thorax 2007 62 9 746 748 17726168
  • Tsai CL Delclos GL Huang JS Hanania NA Camargo CAJr Age-related differences in asthma outcomes in the United States, 1988–2006 Ann Allergy Asthma Immunol 2013 110 4 240 246. e1 23535086
  • Litonjua AA Vitamin D and corticosteroids in asthma: synergy, interaction and potential therapeutic effects Expert Rev Respir Med 2013 7 2 101 104 23547985
  • Lappe JM Heaney RP Why randomized controlled trials of calcium and vitamin D sometimes fail Dermatoendocrinol 2012 4 2 95 100 22928064